Calabrese Salvatore
SEC CIK 1851958 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GANX | Gain Therapeutics, Inc. | CFO | 3,000 | $8,100 | — | 2 | 2022-05-19 | 2022-05-19 |
Most active insiders at GANX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
Calabrese Salvatore made no open-market trades at GANX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-05-23 | 2022-05-19 | GANX | Gain Therapeutics, Inc. | Calabrese Salvatore | CFO | P - Purchase | $2.70 | +3,000 | 3,000 | New | +$8,100 |
| E | 2022-05-19 | 2022-05-19 | GANX | Gain Therapeutics, Inc. | Calabrese Salvatore | CFO | P - Purchase | $8,100.00 | +3,000 | 8,100 | +59% | — |
Purchase Sale Sale after option exercise All abbreviations